Hiroshi Gyotoku

A case of bronchial aspergillosis caused by<i>Aspergillus udagawae</i>and its mycological features

Hiroshi Gyotoku, Koichi Izumikawa, Hideki Ikeda et al. · Medical Mycology · 2012 · 27 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study

Tadaaki Yamada, Yasuhiro Gotô, Hiroshi Tanaka et al. · European Journal of Cancer · 2023 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Remarkable response to pembrolizumab with <scp>platinum‐doublet</scp> in <scp>PD‐L1‐low</scp> pulmonary sarcomatoid carcinoma: A case report

Hirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa et al. · Thoracic Cancer · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

<scp>Pan‐HER</scp> inhibitors overcome lorlatinib resistance caused by <scp>NRG1</scp>/<scp>HER3</scp> activation in <scp><i>ALK</i></scp>‐rearranged lung cancer

Hirokazu Taniguchi, Kazumasa Akagi, Yosuke Dotsu et al. · Cancer Science · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer

Shinsuke Ogusu, Yuhei Harutani, Takehiro Tozuka et al. · Cancer Immunology Immunotherapy · 2023 · 14 citations · Full text

Pharmacy, Oncology, Pharmacology +17